Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ashwin Philips"'
Autor:
Lalatendu Moharana, Soumya Surath Panda, Suma Devaraj, Ghanashyam Biswas, Ganesh Chandra Subudhi, Prasant Kumar Parida, Sourav Kumar Mishra, Jogamaya Pattnaik, Sambit Mohanty, Sukanya Karunanidhi, Sandhya Lakshmi Singuluri, S. V. Saju, Krishna Kumar Rathnam, Amit Sehrawat, Shikha Mudgal, Sunu Lazar Cyriac, Ashwin Philips, Anil Kumar Jose, Prasant Ganesan
Publikováno v:
South Asian Journal of Cancer, Vol 13, Iss 02, Pp 114-120 (2024)
Externí odkaz:
https://doaj.org/article/590a79baadb248298cd247cb3963a8fe
Autor:
Amit Sehrawat, Mridul Khanna, Smita Kayal, Deepak Sundriyal, Shraddha Tiwari, Sunu Cyriac, Praveen Ravishankaran, Jomon Raphael, Dominic Mathew, Soumya Surath Panda, Laltendu Moharana, Sumit Subhadarshi Mohanty, Swati Sucharita Mohanty, Ashwin Philips, Deepak Jain, Pamela Jeyaraj, Parvez Haque David, Jaineet Patil, S.V. Saju, Krishnakumar Rathnam, Neha Sharma, Kaaviya Dheva, Sree Rekha Jinkala, Kalyarasaran Raja, Prasanth Penumadu, Prasanth Ganesan
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEColorectal cancer (CRC) in young adults is a rising concern in developing countries such as India. This study investigates clinicopathologic profiles, treatment patterns, and outcomes of CRC in young adults, focusing on adolescent and young ad
Externí odkaz:
https://doaj.org/article/2c1dec7df5eb440fab598bffa591cd27
Autor:
Adam J. Eqbal, Laura Goodliffe, Hassan Masoom, Muhammad Ajlan, Jessica Hanna, Snezana Vukmirovic-Popovic, Ashwin Philips, Emilie P. Belley-Côté, Omid Salehian, Richard P. Whitlock
Publikováno v:
JACC: Case Reports. 4:1037-1041
Autor:
Ashwin Philips, Manikandan Dhanushkodi, Tenali Gnana Sagar, Prasanth Ganesan, Venkatraman Radhakrishnan, Trivadi S. Ganesan, Jaikumar Ramamurthy
Publikováno v:
Indian journal of hematologyblood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. 34(4)
Rasburicase is a recombinant urate oxidase enzyme approved for use in tumor lysis syndrome (TLS) and it acts by reducing serum uric acid levels. Using rasburicase at the recommended dose of 0.2 mg/kg/day for 5 days is expensive and it is not known wh